All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
  Â
Fasenra 30mg Injection 1ml
Prescription Required
Salt Composition : Benralizumab
Manufacturer : ASTRAZENECA PHARMA INDIA LTD
Origin of Medicine : United Kingdom
1 Prefilled Syringe(s) Of 1ml
PAP Information : Â Â Please contact us for latest updates
Program Overview: ASTRAZENECA PHARMA INDIA LTD, Patient Assistance Program (PAP) is dedicated to helping patients in need of Fasenra 30mg/1ml injection. The program aims to provide eligible patients with access to the medication at a more affordable cost.
Program Benefits: Patient assistance programs (PAPs) are sponsored by pharmaceutical companies, and are an important step towards lowering overall therapy costs for patients. The purpose of these initiatives is to provide financial assistance to patients so they can obtain drugs at low or no cost. MrMed will guide you through the procedure and ensure you receive your PAP medication correctly.Â
Contact us for the latest updates on this exclusive offer.Â
Eligibility Criteria: To qualify for the Fasenra Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for benralizumab 30mg/1ml from a medical Pulmonologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.
Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].
Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by AstraZeneca can avail of it without having to purchase the medication from MrMed.
Patient Assistance Programs
Program Overview: ASTRAZENECA PHARMA INDIA LTD, Patient Assistance Program (PAP) is dedicated to helping patients in need of Fasenra 30mg/1ml injection. The program aims to provide eligible patients with access to the medication at a more affordable cost.
Program Benefits: Patient assistance programs (PAPs) are sponsored by pharmaceutical companies, and are an important step towards lowering overall therapy costs for patients. The purpose of these initiatives is to provide financial assistance to patients so they can obtain drugs at low or no cost. MrMed will guide you through the procedure and ensure you receive your PAP medication correctly.Â
Contact us for the latest updates on this exclusive offer.Â
Eligibility Criteria: To qualify for the Fasenra Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for benralizumab 30mg/1ml from a medical Pulmonologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.
Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].
Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by AstraZeneca can avail of it without having to purchase the medication from MrMed.
Introduction to Fasenra 30mg Injection 1ml
Fasenra 30mg Injection 1ml belongs to a class of drugs called interleukin inhibitors containing the active ingredient Benralizumab. This medication is used to treat severe eosinophilic asthma, a subtype of asthma caused by high levels of eosinophils in the blood and airways. It is also approved for treating eosinophilic granulomatosis with polyangiitis (EGPA), a rare autoimmune disease affecting blood vessels and organs.
Before using Fasenra 30mg Injection 1ml, it's essential to talk to your doctor if you have a history of allergic reactions to certain injections or medicines, have a parasitic infection, and live in an area where parasitic infections are common because this drug may weaken your ability to fight certain types of parasitic infections. If your asthma remains uncontrolled or worsens during treatment, immediately discuss this with your physician. This medicine is not intended for the treatment of sudden asthma attacks. It should not be used as a rescue medication in such situations.
Do not use Fasenra 30mg Injection 1ml unless your doctor advises. Notify your physician if you are pregnant or planning to have a baby; think you may be pregnant so that your doctor may decide to give you this medicine if the expected benefits outweigh any potential risks. It is unknown whether this drug passes into breast milk and is safe to administer during breastfeeding. Inform your physician if you are a nursing mother. This medicine is not recommended for use in children under 18 because the safety and benefits of this medication have not been established in this age group. Parents and caregivers should consult physicians for appropriate asthma management and treatment options for children and adults.
Uses of Fasenra 30mg Injection 1ml
- Treatment of severe eosinophilic asthma
Therapeutic Effects of Fasenra 30mg Injection 1ml
Benralizumab works by binding to a specific protein called interleukin-5 receptor alpha (IL-5Rα) on the surface of eosinophils, a type of white blood cell that plays a key role in the inflammation and narrowing of the airways in asthma. By binding to IL-5Rα, this drug reduces the number of eosinophils in the blood and airways, helping to decrease airway inflammation and improve asthma symptoms.
Interaction of Fasenra 30mg Injection 1ml with other drugs
Inform your physician about all your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Fasenra 30mg Injection 1ml and reduce effectiveness by causing undesirable side effects.
More Information about Fasenra 30mg Injection 1ml
- Store Fasenra 30mg Injection 1ml in a refrigerator at (2°C-8°C).
- Do not freeze
How to consume Fasenra 30mg Injection 1ml
Fasenra 30mg Injection 1ml will be given by injection under the skin (subcutaneous). Your doctor, nurse, or other healthcare professional will show you how to inject the medicine. Do not try to administer the medicine if you are well-trained. Your physician will decide the injection dose based on your disease condition and severity.
Safety Advices for Fasenra 30mg Injection 1ml
 Â
Pregnancy
 Â
Do not use Fasenra 30mg Injection 1ml unless your doctor advises. Notify your physician if you are pregnant or planning to have a baby; think you may be pregnant so that your doctor may decide to give you this medicine if the expected benefits outweigh any potential risks.
 Â
Breast Feeding
 ÂIt is unknown whether Fasenra 30mg Injection 1ml is safe to administer during breastfeeding. Inform your physician if you are a nursing mother.
 Â
Lungs
 Â
Fasenra 30mg Injection 1ml is safe for patients with lung problems. Inform your physician if you have lung disease before starting the treatment.Â
 Â
Liver
  It is unknown whether Fasenra 30mg Injection 1ml is safe for patients with liver problems. Inform your physician if you have any liver disease before starting the treatment. Contact your doctor if you experience any liver-related symptoms.
 Â
Alcohol
 ÂIt is unknown whether consuming alcohol while taking Fasenra 30mg Injection 1ml is safe or not. So, consult your doctor for more information
 Â
Driving
  Some side effects of Fasenra 30mg Injection 1ml may impair your ability to drive or operate machinery unlikely. It is safe to consume this drug.
Side Effects of Fasenra 30mg Injection 1ml
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Serious
- Hypersensitivity reactions
Common
- Headache
- Sore throat
- Rashes
- Fever
- Injection site reactions
- Muscle pain
Word of Advice
Before taking Fasenra 30mg Injection 1ml, your doctor will likely assess your medical history and perform any necessary tests to determine if it is a suitable treatment for your specific condition. They will also provide you with instructions on how to take the medication properly and monitor your progress during treatment.
FAQs
Q 1. How is Fasenra 30mg Injection 1ml administered?
Fasenra 30mg Injection 1ml is administered as a subcutaneous injection (under the skin). The frequency and dosing may vary depending on the specific treatment regimen prescribed by a healthcare provider. It is usually given once every 4 to 8 weeks.
Q 2. Is Fasenra 30mg Injection 1ml a cure for asthma?
Fasenra 30mg Injection 1ml is not a cure for asthma. It is a medication designed to help manage and control severe eosinophilic asthma by reducing airway inflammation and symptoms. While it can significantly improve the quality of life for many people with severe asthma, it does not eliminate the underlying condition, and treatment may need to be continued as long as the condition persists.
Q 3. Can Fasenra 30mg Injection 1ml be used in children?
Fasenra 30mg Injection 1ml is approved for use in adolescents aged 12 years and older with severe eosinophilic asthma. Its safety and efficacy in younger children have not been established, so it is generally not prescribed for those below the approved age range.
Q 4. What formulations are available for Fasenra 30mg Injection 1ml?
Fasenra 30mg Injection 1ml is available in injection form. The specific formulation and dosing will depend on the individual's condition and the healthcare provider's recommendation.
Q 5. Who should not take Fasenra 30mg Injection 1ml?
Fasenra 30mg Injection 1ml may not be suitable for everyone. Individuals with known hypersensitivity or allergy to it or its components should not use it. It is important to inform your physician of any other medical conditions or medications you are taking before starting the treatment.
Q 6. Who should not take Fasenra 30mg Injection 1ml?
Fasenra 30mg Injection 1ml may not be suitable for everyone. Individuals with known hypersensitivity or allergy to it or its components should not use it. It is important to inform your physician of any other medical conditions or medications you are taking before starting the treatment.
Fact Box of Fasenra 30mg Injection 1ml
Molecule name: Benralizumab  | Therapeutic class: Anti-asthmatic agents |
Pharmacological class:Â Interleukin inhibitors | Indications:Â Treatment of severe eosinophilic asthma |
References
- AstraZeneca, Electronic Medicines Compendium (EMC), [Revised on Dec 2022] [Accessed on 1st Sep 2023], https://www.medicines.org.uk/emc/files/pil.8918.pdf
- AstraZeneca, [Revised on 20th Aug 2021] [Accessed on 1st Sep 2023], https://www.astrazeneca.ca/content/dam/az-ca/downloads/productinformation/fasenra-product%20monograph-en.pdf
- Corrado Pelaia et al., Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma, BioMed Research International, 2018, [Accessed on 1st Sep 2023], https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5971345/pdf/BMRI2018-4839230.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
